ArticleFrontiers in oncology2020

Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World Practice.

Ming-Chun Kuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.